Our Portfolio
Our portfolio is led by some of the nation’s most innovative researchers, clinicians, and entrepreneurs. We are proud to partner with visionary founders and their executive teams, supporting them as they bring transformative healthcare technologies to market and make a lasting impact on patients’ lives.
Our Investment Areas
We invest in groundbreaking innovations across pharma, diagnostics, and medical devices & digital health, driving the future of healthcare through technological advancements.
Improves cancer care by delivering drugs directly to tumors for greater impact
(Florham Park, NJ)
DNA/RNA testing for faster, more accurate diagnostics
(Acquired by Hologic)
Boosts community immunity with intranasal vaccine technology
(Ann Arbor, MI)
Aims to prevent influenza and other respiratory diseases through intranasal vaccination
(Madison, WI)
Discovers novel multispecific antibodies to treat cancer and immunological diseases
(Madison, WI)
Targets cancer with precision for more effective, less toxic treatment
(Houston, TX)
Fights cancer with the next generation of EGFR therapies to save more lives
(Ypsilanti, MI)
Therapy for vascular disease to restore blood vessel health
(IPO)
Combats anemia to help patients regain energy and live healthier lives
(IPO)
Genetic engineering for biopharma manufacturing
(Acquired By Cardinal Health)
Dengue fever vaccines for global health protection
(Acquired by Takeda Pharmaceutical)
Non-stimulant therapeutics for ADHD and neuropsychiatric disorders
(Acquired by Otsuka Pharmaceutical Co., Ltd. – OPC)
Brings early autism diagnosis and care to children everywhere
(Plymouth, MN)
Personalizes cancer therapy by predicting each patient’s tumor response
(Madison, WI)
Uses AI to accelerate the sleep testing process and improve the patient care continuum
(Madison, WI)
High-speed microarrays to advance genomic research
(Acquired by Roche)
Molecular biology tools for life science innovation
(Madison, WI)
Early detection of organ rejection in transplant patients
(Acquired by undisclosed)
Offers radiation-free ultrasound for dense breast cancer screening
Helps surgeons navigate precisely for safer, less
invasive operations
(Eden Prairie, MN)
Improves minimally invasive surgery by simplifying tissue removal
(Louisville, CO)
Uses sound waves to non-invasively destroy tumors
(Aquired by K5 Global, Bezos Expeditions, Wellington Management, and other investors)
Bladeless LASIK for safer, more precise vision correction
(Acquired by Advanced Medial Optics)
Image-guided lasers for precision cataract surgery
(Acquired by Alcon Laboratories)
Adhesives and coatings to heal wounds and protect devices
(Acquired by Kensey Nash Corporation)
Rapid lab diagnostics for faster critical test results
(Acquired by Qiagen)
Microwave ablation for minimally invasive tumor treatment
(Acquired by Ethicon – a Johnson & Johnson company)
Improves life for men with BPH by providing a minimally invasive treatment option
(Milwaukee, WI)
Targeting the root of diabetic vascular disease
(Milwaukee, WI)
Biological therapies for complex diseases in immunology
(Milwaukee, WI)
3D-printed implants to accelerate and strengthen bone healing
(Acquired By J&J DePuy and Medtronic)
Imaging and radiation integration for precise cancer targeting
(Acquired by Accuray)
Treats glaucoma without incisions, preserving
vision with laser precision
(Aliso Viejo, CA)
Brings accessible, specialized care to women
through a virtual clinic
(Minneapolis, MN)
GDXI
Phone-based ECG technology for expanded heart care access
(Acquired by Covance)
AI insights from imagining to guide cancer care
(Aquired by Genentech)
Zystor
Therapies for rare lysosomal storage diseases
(Acquired By BioMarin Pharmaceutical)